UNIV DEGLI STUDI DI URBINO CARLO BO has a total of 11 patent applications. It increased the IP activity by 25.0%. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), Italy and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and electrical machinery and energy are SHAANXI BUCHANG PHARMA CO LTD, SHANXI ZHENDONG ANTE BIOPHARMACEUTICAL CO LTD and ORTHOGENICS AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Italy | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Electrical machinery and energy | |
#4 | Organic fine chemistry | |
#5 | Biotechnology | |
#6 | Basic materials chemistry | |
#7 | Computer technology | |
#8 | Semiconductors |
# | Technology | |
---|---|---|
#1 | Electric discharge tubes | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Peptides | |
#6 | Pigments | |
#7 | Heterocyclic compounds | |
#8 | Electric digital data processing | |
#9 | Semiconductor devices | |
#10 | Measuring electric variables |
# | Name | Total Patents |
---|---|---|
#1 | Fusi Vieri | 5 |
#2 | Piergiovanni Maurizio | 3 |
#3 | Cappiello Achille | 3 |
#4 | Termopoli Veronica | 3 |
#5 | Famiglini Giorgio | 3 |
#6 | Fraternale Alessandra | 2 |
#7 | Lucchetti Francesca | 2 |
#8 | Piersanti Giovanni | 2 |
#9 | Papa Stefano | 2 |
#10 | Formica Mauro | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019123408A1 | Device for emulating energy sources used to power embedded systems/devices | |
EP3713952A1 | Method for the synthesis of glutathione derivatives | |
WO2019077527A1 | Heterocyclic compounds as fluorescent probes for detection in biological systems | |
EP3478282A1 | Pharmaceutical composition of [ (3-hydroxy-4 -pyron-2-yl) methyl]-amine derivatives and dna demethylating agents and their use as anti-neoplastic drugs | |
US2020300822A1 | Machine for chemical analysis comprising the combination of electron ionization mass spectrometry with liquid chromatography |